Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.
The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| subacromial injection | Active Comparator | ultrasound (US)-guided subacromial injection |
|
| acromioclavicular joint and subacromial injection | Active Comparator | ultrasound (US)-guided acromioclavicular joint and subacromial injection |
|
| suprascapular nerve block | Active Comparator | ultrasound (US)-guided suprascapular nerve block |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bupivacaine and methylprednisolone | Drug | 5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analogue Scale (VAS) | for pain. 0: no pain at all, 10: worst pain imaginable | six month |
| Measure | Description | Time Frame |
|---|---|---|
| Shoulder pain and disability index (SPADI) | This scale was developed to measure pain and disability associated with shoulder pain. It consists of two parts evaluating pain and disability. | six month |
| Short-Form 12 (SF-12) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Burcu Metin Ökmen, Assoc. Prof | University of Health Sciences, Yuksek Ihtisas Training and Research Hospital | Principal Investigator |
| Korgün M Ökmen, Assoc. Prof | Bursa Yuksek Ihtisas Training and Research Hospital | Study Chair |
Not provided
Not provided
prospective,randomized controlled, single blind
Not provided
Not provided
The patients were followed up and questioned by the evaluator, who was blind to the type of injection administered to the patient.
| bupivacaine and methylprednisolone | Drug | 5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint |
|
| bupivacaine and methylprednisolone | Drug | suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone |
|
|
The SF-12 has a physical (SF12-PCS) and mental (SF12-MCS) state assessment scale
| six month |
| ID | Term |
|---|---|
| D019534 | Shoulder Impingement Syndrome |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D000070599 | Shoulder Injuries |
| D014947 | Wounds and Injuries |
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D008775 | Methylprednisolone |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
| D011239 | Prednisolone |
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
Not provided
Not provided